Article
Prevalence of colorectal cancer biomarkers and their impact on clinical outcomes in Riyadh, Saudi Arabia.
PloS one - 1 Jan 2021
Alharbi Amjad, Bin Dokhi Haifa, Almuhaini Ghadir, Alomran Futoon, Masuadi Emad, Alomran Nouf
Abstract excerpt
OBJECTIVES: KRAS, NRAS, and BRAF mutations are commonly present in colorectal cancer (CRC). We estimated the frequency of KRAS, NRAS, and BRAF mutations and assessed their impact on survival and other clinical variables among Saudi patients. DESIGN: Retrospective cohort study design. SETTINGS: Oncology department of a tertiary hospital in Riyadh, Saudi Arabia. We gathered information from 2016 to 2018....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
